Our Company

We Help Improve Lives in Hundreds of Ways

Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2014, the Group employed around 119,000 people and had sales of EUR 42.2 billion. Capital expenditures amounted to EUR 2.5 billion, R&D expenses to EUR 3.6 billion. These figures include those for the high-tech polymers business, which was floated on the stock market as an independent company named Covestro on October 6, 2015. For more information, go to www.bayer.com.

Learn more by:

Names, Facts, Figures about Bayer


Bayer is an innovation company with a more than 150-year history and core competencies in the fields of health care and agriculture. We develop new molecules for use in innovative products and solutions to improve the health of humans, animals and plants. Our research and development activities are based on a profound understanding of the biochemical processes in living organisms.

BU: 1 An analysis by well-known branding agency Interbrand in 2015 valued the Bayer brand at €6.3 billion.
Our goal is to achieve and sustain leadership positions in our markets, thus creating value for our customers, stockholders and employees. To this end, our strategy is designed to help solve some of the most pressing challenges facing mankind, and by doing this exceptionally well we aim to strengthen the company’s earning power.
We are committed to operating sustainably and to addressing our social and ethical responsibilities as a corporate citizen, while at the same time respecting the interests of all our stakeholders. Employees with a passion for innovation will enjoy excellent development opportunities at Bayer.

All this is part of our mission: Bayer: Science For A Better Life

Focus on Life Science Businesses


Following the economic and legal separation of our MaterialScience business, now Covestro*, Bayer has charted the course for its successful development as a Life Science company. In this connection, we have realigned our corporate structure. Since January 1, 2016, Bayer’s core business has been managed by three divisions: Pharmaceuticals, Consumer Health and Crop Science. Animal Health is a separate reporting segment.

Our Life Science businesses hold leading positions in innovation-driven growth markets. Together they make up a strong, attractive and balanced portfolio that is resistant to fluctuations in demand and to potential risks. The previous structure comprising a strategic management holding company and operational subgroups has thus been replaced by an integrated organization under the umbrella of the strong Bayer brand.

Organization of Bayer


organization of bayer organization of bayer organization of bayer

Business operations are the responsibility of the divisions


The Pharmaceuticals Division focuses on prescription products, especially for cardiology and women’s healthcare, and on specialty therapeutics in the areas of oncology, hematology and ophthalmology. The division also comprises the Radiology Business Unit which markets contrast-enhanced diagnostic imaging equipment together with the necessary contrast agents.
The Consumer Health Division markets mainly non-prescription products in the dermatology, dietary supplement, analgesic, gastrointestinal, allergy, cold and flu, foot care, sun protection and cardiovascular risk prevention categories. These products include globally known brands such as Claritin™, Aspirin™, Aleve™, Bepanthen™/Bepanthol™, Canesten™, Dr. Scholl’s™ and Coppertone™.
The Crop Science Division has businesses in seeds, crop protection and non-agricultural pest control. It is organized into two operating units: Crop Protection/Seeds and Environmental Science. Crop Protection/Seeds markets a broad portfolio of high-value seeds along with innovative chemical and biological pest management solutions, at the same time providing extensive customer service for modern and sustainable agriculture. Environmental Science focuses on non-agricultural applications, with a broad portfolio of pest control products and services for areas ranging from the home and garden sector to forestry.
Our products for farm and companion for animals are managed in the Animal Health business unit, which reports to the Board member responsible for the Crop Science Division.

Central Service Functions


The Corporate Functions and Bayer Business Services operate as Group-wide competence centers in which business support services are bundled.
Currenta  is the service company responsible for managing and operating the Chempark sites in Leverkusen, Dormagen and Krefeld-Uerdingen.
Covestro* is a leading supplier of high-tech polymer materials and develops innovative product solutions for a wide variety of everyday uses.

Corporate Governance
Dual governance system with the following governance bodies:
Board of Management: Eight members.
Supervisory Board: 20 members, Chairman: Werner Wenning

Products


With our products, we are contributing to finding solutions to some of the major challenges of our time. The growing and increasingly aging world population requires improved medical care and an adequate supply of food. Bayer is improving peo­ple’s quality of life by preventing, alleviating and curing diseases. And we are helping to provide a reliable supply of high-quality food, feed and plant-based raw materials.


Best-selling Bayer products are:
In the health care field: Xarelto™, Kogenate™, Betaferon™/Betaseron™/Mirena product family , Nexavar™
The key brands in the agriculture field are: Confidor™ / Gaucho™, Nativo™ product family, Nunhems™, Basta™/ Liberty™, Prosaro™ product family

Locations
The Bayer Group comprises around 302 consolidated companies** in 75 countries throughout the world. Global headquarters are in Leverkusen, Germany.
** fully consolidated subsidiaries (as of Dec. 31, 2014)

Workforce
On September 30, 2015, the Bayer Group had 102,168 employees worldwide.

bayer employees

Read more about Bayer employees
Jobs and Career 

Bayer Stock included in nearly all the major share indices traded on all German stock exchanges dividend per share: EUR 2.25 (2014)
Bayer Group Key Data


(as of December 31, 2014)
* formerly Bayer MaterialScience more


Consumer Health


With its broad range of iconic brands, Consumer Health aims to support people do more for their health and well-being. This not only increases personal quality of life but can also greatly reduce health care costs.

The rapid pace of change in global health care markets is characterized by an increasing trend toward consumer-centered health care. Consumer Health’s own rich history in the self-care arena began in 1899 with the introduction of Bayer’s flagship global consumer brand, Bayer Aspirin™.

Today, the division brings consumers some of the world’s best-known and most trusted over-the-counter (OTC) medications, nutritional supplements and other self-care products. The division’s balanced portfolio includes strong brands in all the categories in which it competes, including Allergy, Analgesics, Cardiovascular Risk Prevention, Cough & Cold, Dermatology, Foot Care, Gastrointestinals, Nutritionals and Sun Care.



The Consumer Health Division is a leader among the top consumer health care companies in the world. The division operates in more than 100 countries and maintains 18 manufacturing sites and four product research and development centers. The goal of Consumer Health is to further expand its strong position in the market aiming to lead the market in the countries and categories in which they compete. Key focus areas include driving forward the integration of the consumer care businesses acquired in 2014 from Merck & Co., Inc., and Dihon Pharmaceutical Group Co., Ltd. in China.

"At Consumer Health, we are working together to lead a global transformation – from treating illness to promoting wellness. We are working together to help every consumer we serve lead a better, healthier life through science-driven innovations that improve wellness, treat everyday ailments and prevent disease."
- Erica Mann, Member of the Board of Management of Bayer AG and Head of the Consumer Health Division

With more than 170 brands around the world and 17 OTC brands generating annual sales of more than €100 million each, the Consumer Health Division is well positioned to take advantage of the sustained growth forecast for the OTC market.

In fact, some of the world’s best-known and most trusted over-the-counter medications, nutritional supplements and other self-care products are part of the Consumer Care portfolio, including Alka Seltzer™, Aleve™, Aspirin™, Bepanthen™/Bepanthol™, Berocca™, Canesten™, Claritin™, Coppertone™, Dr. Scholl’s™, Elevit™, Iberogast™, MiraLAX™, One a Day™, Rennie™, Redoxon™ and Supradyn™.



Pharmaceuticals


The Pharmaceuticals Division focuses on prescription products, especially for women’s healthcare and cardiology, and also on specialty therapeutics in the areas of oncology, hematology and ophthalmology. The division also comprises the Radiology Business Unit which markets contrast-enhanced diagnostic imaging equipment together with the necessary contrast agents.

With our innovative products, we seek to achieve a significant therapeutic benefit for patients, while at the same time satisfying the growing requirements of physicians and health insurers.

In the medium term, our recently launched products such as Xarelto™, Eylea™, Stivarga™, Xofigo™ and Adempas™ in particular should contribute to increased sales. To safeguard our growth in the long term, we will be further expanding our early-stage research activities and driving forward the clinical development of active ingredient candidates discovered in-house. Moreover, we will continue to systematically supplement our development portfolio by means of licensing agreements and acquisitions.